These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 25726787)

  • 1. [Tactics of management of preschool children with different variants of speech delay].
    Lar'kina EV; Khaletskaia OV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2014; 114(12):94-98. PubMed ID: 25726787
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Atomoxetine and piracetam in the treatment of attention deficit hyperactivity disorder in children].
    Zavadenko NN; Suvorinova NIu
    Zh Nevrol Psikhiatr Im S S Korsakova; 2008; 108(7):43-7. PubMed ID: 18833117
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Speech disorders in children: early diagnosis and treatment].
    Zavadenko NN
    Zh Nevrol Psikhiatr Im S S Korsakova; 2016; 116(12):119-125. PubMed ID: 28139638
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The treatment of attention deficit hyperactivity disorder with comorbid tic hyperkinesis].
    Chutko LS; Surushkina SIu; Nikishena IS; Iakovenko EA; Lapshina OV; Anisimova TI
    Zh Nevrol Psikhiatr Im S S Korsakova; 2008; 108(2):66-8. PubMed ID: 18646384
    [No Abstract]   [Full Text] [Related]  

  • 5. [Electroencephalographic study of children with attention deficit hyperactivity disorder before and after treatment with strattera].
    Nikishina IS; Chutko LS; Surushina SIu; Iakovenko EA; Kropotov IuD
    Zh Nevrol Psikhiatr Im S S Korsakova; 2008; 108(12):60-2. PubMed ID: 19253469
    [No Abstract]   [Full Text] [Related]  

  • 6. [Effectiveness of strattera in children and adolescents with attention deficit hyperactivity disorder].
    Vakula IN; Vasianina IuSh; Gorbunova ZKh; Nikiforova EIu; Ponomarenko EI
    Zh Nevrol Psikhiatr Im S S Korsakova; 2009; 109(8):42-4. PubMed ID: 19738568
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dose-dependent Raynaud's phenomenon developing from use of atomoxetine in a girl.
    Gökçen C; Kutuk MO; Coşkun Ş
    J Child Adolesc Psychopharmacol; 2013 Aug; 23(6):428-30. PubMed ID: 23952193
    [No Abstract]   [Full Text] [Related]  

  • 8. [Attention deficit hyperactivity disorder: clinical heterogeneity and possibilities of therapy].
    Chutko LS; Surushkina SIu
    Zh Nevrol Psikhiatr Im S S Korsakova; 2008; 108(8):75-80. PubMed ID: 19115509
    [No Abstract]   [Full Text] [Related]  

  • 9. Long-term treatment with atomoxetine for attention-deficit/hyperactivity disorder symptoms in children and adolescents with autism spectrum disorder: an open-label extension study.
    Harfterkamp M; Buitelaar JK; Minderaa RB; van de Loo-Neus G; van der Gaag RJ; Hoekstra PJ
    J Child Adolesc Psychopharmacol; 2013 Apr; 23(3):194-9. PubMed ID: 23578015
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Factors associated with atomoxetine efficacy for treatment of attention-deficit/hyperactivity disorder in children and adolescents.
    Scott NG; Ripperger-Suhler J; Rajab MH; Kjar D
    J Child Adolesc Psychopharmacol; 2010 Jun; 20(3):197-203. PubMed ID: 20578932
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A pilot study of atomoxetine in young children with attention-deficit/hyperactivity disorder.
    Kratochvil CJ; Vaughan BS; Mayfield-Jorgensen ML; March JS; Kollins SH; Murray DW; Ravi H; Greenhill LL; Kotler LA; Paykina N; Biggins P; Stoner J
    J Child Adolesc Psychopharmacol; 2007 Apr; 17(2):175-85. PubMed ID: 17489712
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Does atomoxetine improve executive function, inhibitory control, and hyperactivity? Results from a placebo-controlled trial using quantitative measurement technology.
    Wehmeier PM; Schacht A; Ulberstad F; Lehmann M; Schneider-Fresenius C; Lehmkuhl G; Dittmann RW; Banaschewski T
    J Clin Psychopharmacol; 2012 Oct; 32(5):653-60. PubMed ID: 22926599
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Suboptimal dosing of Strattera (atomoxetine) for ADHD patients.
    Clemow DB
    Postgrad Med; 2014 Sep; 126(5):196-8. PubMed ID: 25420287
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Screening for speech and language delay in preschool children: recommendation statement.
    US Preventive Services Task Force
    Pediatrics; 2006 Feb; 117(2):497-501. PubMed ID: 16452370
    [No Abstract]   [Full Text] [Related]  

  • 15. [Developmental dysphasia in children: perspectives of neurotrophic therapy].
    Zavadenko NN; Kozlova EV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2013; 113(5 Pt 2):43-7. PubMed ID: 23739513
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effectiveness of atomoxetine and quality of life in children with attention-deficit/hyperactivity disorder as perceived by patients, parents, and physicians in an open-label study.
    Wehmeier PM; Dittmann RW; Schacht A; Minarzyk A; Lehmann M; Sevecke K; Lehmkuhl G
    J Child Adolesc Psychopharmacol; 2007 Dec; 17(6):813-30. PubMed ID: 18315453
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Focal dystonia and speech impairment responding to anticholinergic therapy.
    Vogels OJ; Maassen B; Rotteveel JJ; Merx JL
    Pediatr Neurol; 1994 Nov; 11(4):346-8. PubMed ID: 7702699
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Screening for speech and language delay in preschool children: more answers are needed.
    Wegner L
    Pediatrics; 2006 Feb; 117(2):533-4. PubMed ID: 16452377
    [No Abstract]   [Full Text] [Related]  

  • 19. Fast vs. slow switching from stimulants to atomoxetine in children and adolescents with attention-deficit/hyperactivity disorder.
    Cardo E; Porsdal V; Quail D; Fuentes J; Steer C; Montoya A; Anand E; Escobar R
    J Child Adolesc Psychopharmacol; 2013 May; 23(4):252-61. PubMed ID: 23683140
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A multi-centre, randomised, open-label study of atomoxetine compared with standard current therapy in UK children and adolescents with attention-deficit/hyperactivity disorder (ADHD).
    Prasad S; Harpin V; Poole L; Zeitlin H; Jamdar S; Puvanendran K;
    Curr Med Res Opin; 2007 Feb; 23(2):379-94. PubMed ID: 17288692
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.